| Original language | English |
|---|---|
| Pages (from-to) | 944-947 |
| Number of pages | 4 |
| Journal | British Journal of Haematology |
| Volume | 185 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 2019 |
Cite this
Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib. / Mian, M.; Pescosta, N.; Badiali, S.; Cappelletto, P.C.; Marcheselli, L.; Luminari, S.; Patriarca, F.; Zambello, R.; Pascarella, A.; Tagariello, G.; Marabese, A.; Mondello, P.; Billio, A.; Cortelazzo, S.
In: British Journal of Haematology, Vol. 185, No. 5, 2019, p. 944-947.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib
AU - Mian, M.
AU - Pescosta, N.
AU - Badiali, S.
AU - Cappelletto, P.C.
AU - Marcheselli, L.
AU - Luminari, S.
AU - Patriarca, F.
AU - Zambello, R.
AU - Pascarella, A.
AU - Tagariello, G.
AU - Marabese, A.
AU - Mondello, P.
AU - Billio, A.
AU - Cortelazzo, S.
N1 - Export Date: 3 July 2019 CODEN: BJHEA Correspondence Address: Mian, M.; Department of Haematology & CBMT, Hospital of BolzanoItaly; email: m.mian@med-sci.eu
PY - 2019
Y1 - 2019
U2 - 10.1111/bjh.15645
DO - 10.1111/bjh.15645
M3 - Article
VL - 185
SP - 944
EP - 947
JO - British Journal of Haematology
JF - British Journal of Haematology
SN - 0007-1048
IS - 5
ER -